Evaluation of CD20, CD22, and HLA-DR targeting for radioimmunotherapy of B-cell lymphomas.
Pagel JM, Pantelias A, Hedin N, Wilbur S, Saganic L, Lin Y, Axworthy D, Hamlin DK, Wilbur DS, Gopal AK, Press OW.
Pagel JM, et al. Among authors: wilbur ds, wilbur s.
Cancer Res. 2007 Jun 15;67(12):5921-8. doi: 10.1158/0008-5472.CAN-07-0080.
Cancer Res. 2007.
PMID: 17575162